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Abstract 
The marine environment shows a vast ecological, chemical, and biological 
diversity, from unicellular microorganisms to vertebrates, with more than 300 
000 described species of plants and animals. Marine microorganisms are 
frequently members of complex communities in which competition for limited 
space and resources can be strong. Marine bacteria represent an emerging 
source of natural products as they produce a variety of structurally diverse and 
biologically active secondary metabolites. The overall aim of this work is to 
contribute to the discovery of novel marine bioactive compounds obtained 
from bacterial communities that display antagonistic biological activity. This 
was achieved by using the nematode Caenorhabditis elegans as a model 
system to detect and identify bioactive bacterial compounds that target 
multicellular eukaryotes. C. elegans is a free –living terrestrial nematode that 
feeds on bacteria, and can be easily grown and manipulated under laboratory 
conditions. Previous work isolated bacterial DNA from the seaweed Ulva 
australis and identified some genetic elements displaying bioactivity when 
expressed in the heterologous Escherichia coli host. This work used that library 
to identify the most toxic clone (i.e., JJ117) by quantifying the levels of 
toxicity towards C. elegans. To determine which genes were specifically 
responsible for this activity a random transposon mutant library of JJ117 was 
created and screened for a loss of toxicity towards C. elegans. Loss of 
nematocidal activity for 18 selected clones was then further characterised via a 
toxicity assay. Finally, transposon disrupted genes were sequenced to identify 
the specific genetic elements in these clones that are responsible for the toxic 
activity. 
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  Introduction  
 
1.1  Bacterial interactions in the marine environment  
 
The marine environment occupies ~ 70 % of the Earth‟s surface, and 
contributes  ~ 50 % of its photosynthetically reduced carbon (Ainsworth et al., 
2010). Marine environments show a vast diversity of life, with 34 of the 36 
phyla of life being present. As life originated in the ocean, there is a vast 
ecological, chemical, and biological diversification of both microorganisms 
and vertebrates, with about one million species described so far. Marine sessile 
microorganisms, such as seaweeds, sponges, and corals, are often colonized by 
a large number and diversity of bacteria, with they can have either positive, 
neutral or negative interactions (Ainsworth et al., 2010; Egan et al., 2012; 
Hollants et al., 2013). In recent years, disease caused by microorganisms has 
been increasingly recognized as a major negative interaction that influences 
the composition and function of benthic community members (Bourne et al., 
2009; Egan et al., 2013). Disease of marine invertebrates and macroalgae has 
also been clearly linked to changes in the marine environment, such as 
anthropogenic stressors (e.g. pollutants, urbanization etc.) and climate change 
(Campbell et al., 2011). However, linking bacterial pathogens to particular 
diseases in the marine environment is often challenging (Rosenberg et al., 
2009; Egan et al., 2013). Previous in vitro studies have shown that two 
bacterial strains, Nautella italic R11 and Phaeobacter gallaeciensis LSS9, can 
cause bleaching symptoms in Delisea pulchra a red macroalgae, which suffers 
from a bleaching desease that is characterized by a loss of pigments (Campbell 
et al., 2011). Microorganisms may be free-living, epi- or endo-biotic, living as 
commensals, mutualists, or obligate symbionts of larger eukaryotic organisms. 
In many cases, marine microorganisms are members of complex communities 
in which competition for limited space and resources can be intense (Hibbing 
et al., 2010). It has been previously shown that bacteria from a wide range of 
marine environments, including sediments, seawater, biofilms, and those 
created by living in association with invertebrates and algae, possess 
antagonistic activities (Wietz et al., 2013). Antagonistic interactions may play 
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significant roles in structuring these communities, where the evolutionary 
advantages afforded by an effective chemical defense may be crucial for 
survival (Wietz et al., 2013). The interactions between the epibiotic 
microorganisms (i. e. bacteria, viruses and fungi) and their host, in which the 
microorganisms acquire nutrients from the eukaryotic host, while the host may 
benefit from the wide range of bioactives produced by its associated 
microorganisms, seems to be widespread in the marine environment (Penesyan 
et al., 2010). For example, the gamma-proteobacterium Pseudoalteromonas  
tunicata, known for the production of several bioactive compounds, is 
proposed to play a role in defending the host against surface colonisation by 
producing antimicrobial, antilarval and antiprotozoan compounds (Penesyan et 
al., 2010). Likewise, the surfaces of the healthy embryos of the lobster 
Homarus americanus are covered almost exclusively by a single Gram-
negative bacterium that produces an antifungal compound highly effective 
against the fungus Lagenidium callinectes, a common pathogen of many 
crustaceans (Penesyan et al., 2010). The production of antimicrobials by 
epiphytic microorganisms could also give the producers a distinct advantage in 
competition with other surface-dwelling microbes. This is especially important 
given the fierce competition that exists on the surfaces of marine living 
organisms, which are relatively rich in nutrients compared to the dissolved 
aquatic medium, and, therefore, are attractive for numerous microorganisms. 
The fact that many marine microorganism-host associations are based on 
metabolic or chemical interactions may explain the abundance of bioactive 
producing bacteria on living surfaces (Penesyan et al., 2010).  
 
1.2 Secondary metabolites from marine bacteria 
 
Secondary metabolites from marine bacteria function in a variety of processes 
including nutrient acquisition (Hider et al., 2010), chemical communication 
(Straight et al., 2009) and competition. The importance that these secondary 
metabolites play in the control of infectious and parasitic organisms was for 
many years largely overlooked (Donia et al., 2013). Fuelled by advances in 
molecular biology and analytical chemistry, researchers are now beginning to 
appreciate the extent to which bacterial small molecules mediate ecologically 
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relevant antagonistic interactions in the marine environment. The structural 
homology of a number of metabolites isolated from marine microorganisms 
with natural products also found in terrestrial microbial sources further 
imposes questions about the true biosynthetic origin of these molecules.  
The marine bacterial genus Pseudoalteromonas contains numerous species 
which synthesize biologically active molecules. Many of these species have 
shown an ability to produce an array of low- and high-molecular-weight 
compounds with antimicrobial, algicidal, neurotoxic, and other 
pharmaceutically relevant activities (Ballestriero et al., 2010). P. tunicata 
strain D2 is the most comprehensively studied species within this genus. This 
species colonizes sessile eukaryotes such as algae and tunicates and is a 
producer of several compounds with inhibitory activities against a range of 
organisms. Although the identity of several of these compounds remains 
unknown, they target a range of bacteria, fungi, invertebrate larvae, diatoms, 
algal spores, and protozoa. Furthermore, a recent analysis of the P. tunicata 
D2 genome revealed properties characteristic of pathogens such as curli, 
several proteases, and homologs to virulence regulators (Ballestriero et al., 
2010). Hence, P. tunicata D2 is a powerful model system in which to 
investigate bioactive compounds and their mode of action, including those that 
serve as virulence factors (Ballestriero et al., 2010).  
In addition, previous studies have shown that the Roseobacter clade is one of 
the major marine groups that is well represented across diverse marine 
habitats, from coasts to open oceans, and from sea ice to sea floor (Giovannoni 
et al., 2000). This clade contains 36 described species, where the first members 
described were Roseobacter litoralis and Roseobacter denitrificans, both pink-
pigmented bacteriochlorophyll α-producing strains isolated from marine algae 
(Shiba et al., 1991). These members also produce secondary metabolites 
(Lafay et al., 1195). In bacteria, this is often the basis for chemical signaling 
and defence, as well as host-microbe interactions. Previously it was found that 
many Roseobacters, particularly those within the Roseobacter galleaeciensis 
lineage, produce bioactive compounds. Researchers also isolated another R. 
galleaeciensis, able to produce a novel antibiotic, tropodithietic acid, which is 
effective against marine bacteria and algae (Brinkhoff et al., 2004). It has also 
been previously found that different strains were able to produce secondary 
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metabolities such as Roseobacter algicola (Lafay et al., 1995) and 
Oceanibulbus indoliflex, which produce the antimicrobial compound 
tryptanthrin (Wagner et al., 2004). These organisms are also interesting as they 
have the potential to be applied as fish probiotics or as a source of 
pharmaceutical compounds. The application of either organisms or the 
compounds that they produce requires that they do not cause any side effects 
such as toxicity in eukaryotic organisms. The purpose of this study was to 
determine if the DNA library or the compounds that it encodes, display 
toxicity towards the eukaryotic C.elegans. 
 
1.3 C. elegans as a model organism 
 
In order to detect and identify bacterial bioactive compounds that target 
multicellular eukaryotes, the nematode C. elegans can serve as a model 
system.  
C. elegans is a free living terrestrial nematode that feeds on bacteria, and was 
first described by Emile Maupas (1900). Today C. elegans is used to study a 
large variety of biological processes including apoptosis, cell signalling, cell 
cycle progression, cell polarity, genetic regulation and metabolism. But why 
C. elegans? Firstly, it is easy to grow, observe, analyse, and manipulate under 
laboratory conditions. C. elegans commonly grows in the soil and feeds on 
various bacteria. C.elegans, can readily be raised in the laboratory on a diet of 
E. coli. Previous studies on C. elegans have provided many insights into the 
underlying mechanism of human diseases, for example, in the elucidation of 
molecular pathways involved in Parkinson‟s Disease (Harrington et al., 2010). 
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Figure. 3. C.elegans life cycle: The entire life cycle takes 3.5 days at 20 C (3 days at 25 C and 6 days at 
15 C). The life cycle starts from the first larval stage, only 250 µm long. Post embryonic development 
involves growth through four larval stages (L1 to L4) in 28 hours, before the final moult to produce the 
adult, after 18 hours. In the absense of food and high density of population there is another stage called 
dauer.This stage can remain viable for few months and when food becomes available , moults to become 
a normal L4 larva.(Sifri et al., 2005). 
 
The nematode C. elegans is a model organism that is used in many fields such 
as cellular biology, developmental biology and neurobiology, and more 
recently also as a model organism for the study of host-microbial interactions, 
with a focus on pathogenesis and drug discovery (Siffree et al., 2005). 
Focusing on the anatomy of C. elegans, there are two sexes, male and 
hermaphrodite. The hermaphrodite produces both sperm and oocytes and can 
reproduce by self-feritilization, without mating. The male produces only sperm 
and so to reproduce must mate with a hermaphrodite. Under standard 
laboratory conditions, the growth of C. elegans is rapid. The entire life cycle 
(Fig.1) takes 3.5 days at 20ºC, 3 days at 25 ºC, and 6 days at 15 ºC. C. elegans 
has a short generation time and can produce about 300 progeny per self-
fertilizing hermaphrodite, which enables the large-scale production of several 
million individuals per day. Post embryonic development involves growth 
through four larval stages (L1 to L4) in 28 hours, before the final moult to 
produce the adult, in 18 hours. The life cycle starts from the first larval stage 
(L1), when the worms are only 250 µm long. In the absense of food and high 
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density of population there is another stage called dauer. This stage can remain 
viable for months, and when food becomes available the dauer worm moults to 
become a normal L4 larva (Siffree et al., 2005). C. elegans  is  able  to  
distinguish  between  toxic  and  nontoxic  bacterial  colonies (Ballestriero et 
al., 2010). In the natural environment the nematode C. elegans has the 
possibility to feed on many microorganisms. Some of these are an excellent 
food source but others act as repellents or are poisonous. To avoid the harm 
caused by bad food the nematode has developed important survival 
mechanisms, sophisticated strategies to distinguish and respond to different 
food sources, including the avoidance of noxious substances and attraction to 
nutrients or signals (Schulenburg et al., 2007). Two main grazing mechanisms 
have been found in C. elegans. The first is the ability of the nematode to detect 
repellent olfactory cues produced by microorganisms, which results in an 
immediate avoidance behaviour in C. elegans (Pradel et al., 2007). For 
example, C. elegans responded differently to diverse pathogenic species, such 
as Salmonella enterica, Enterecoccus faecalis and Streptococcus spp and to 
probiotic bacteria (Lactobacillus paracasei, Bifidobacterium spp).  
C. elegans also recognises toxic solutes, such as alcohol, oxygen reactive 
species, heavy metals and sulphydryl-reactive compounds, which induce the 
production of cellular stress proteins, by inhibiting feeding. The second main 
grazing strategy of C. elegans, involves the ingestion of pathogenic bacteria by 
the nematode that induces a process of aversive learning, leading to the ability 
to subsequently avoid the pathogen (Zhang 2005). Those aspects of C. elegans 
make the nematode an excellent model for studies on the discovery of 
bioactive compounds in marine ecosystem (Boyd et al. 2010) (Penesyan, 
2012)   
 
1.4 Approaches to Metagenomic and Genomic Analysis 
 
Metagenomics is the study of the collective genomes of the members of a 
microbial community. It involves cloning and analyzing the genomes without 
culturing the organisms in the community, there by offering the opportunity to 
describe the planet‟s diverse microbial inhabitants, many of which cannot yet 
be cultured (Sabree et al., 2009). 
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Prokaryotes are the most physiologically diverse and metabolically versatile 
organisms on our planet. Bacteria vary in the ways that they forage for food, 
transduce energy, contend with competitors, and associate with allies. 
However the vast majority of marine bacteria have not been cultivated in the 
laboratory, and almost all of our knowledge of microbial life is based on the 
few organisms raised in pure culture. The challenge that has frustrated 
microbiologists for decades is how to access the microbial diversity that 
cannot be cultured under laboratory conditions. Many clever cultivation 
methods have been devised to expand the range of organisms that can be 
cultured (Handelsman, 2004). However, knowledge of the uncultured world is 
slim, so it is difficult to use a process based on rational design to coax many of 
these organisms into culture. Metagenomics provides an additional set of tools 
to study uncultured species. This new field offers an approach to studying 
microbial communities as entire units, without cultivating individual members.  
This functional metagenomic approach involves the direct extraction of DNA 
from a community so that all of the genomes of organisms in the community 
are pooled. These genomes are usually fragmented and cloned into an 
organism (commonly E. coli) that can be cultured to create „metagenomic 
libraries‟ (Figure. 2), and these libraries are then subjected to analysis based on 
DNA sequence or the functions conferred on the surrogate host by the 
metagenomic DNA (Sabree et al., 2009). They also can be screened against 
eukaryotic model as C.elegans, which is the main tool used in this thesis.   
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Figure 4: Construction of metagenomic libraries. Schematic representation of construction of libraries 
from environmental samples. DNA is extracted directly from the community, cloned into a surrogate 
host, and then studied by sequencing or screening for expression of activities of interest. 
 
 1.5 Background of the Project and Aims 
 
The main goal of this thesis is to identify marine bioactive compounds 
produced by the bacteria that live on the surface of the seaweed Ulva australis 
and that have toxicity against C. elegans. C. elegans serves a model organism, 
with the aim to identify marine bioactives that are toxic towards eukaryotes. 
Prior studies, through a metagenomic analysis of the epiphytic microbial 
community of U. australis, created large insert (40kb) fosmid metagenomic 
libraries, of the algal associated community (Burke et al.,2010). A 
metagenomic library screening was also performed, and six toxic clones jj29, 
jj30, jj55, jj71, jj83, jj117 were found to display anti-nematode activity. The 
hypothesis for this thesis is that these six clones contain/produce novel anti-
nematode compound/metabolites. 
The steps involved in this project to identify the toxic compounds are: 
 Confirm the toxicity of the selected clones; 
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 Create a transposon (Tn) mutant library of these clones; 
 Screen the (Tn) mutants for a loss of toxicity using C. elegans;  
 Transposon insertion mapping to identify the genes responsible for toxicity 
against C. elegans. 
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Materials and Methods  
 
 2.1 Strains and growth conditions 
 
The nematode C. elegans N2 Bristol strain was obtained from the 
Caenorhabditis Genetics Centre (CGC) (Minneapolis, MN, USA). Nematodes 
were maintained on Nematode Growth Medium (NGM) agar seeded with E. 
coli OP50 as a food source at 25ºC. NGM plates were prepared by adding 3 
g/L NaCl, 7.5 g/L peptone, 17 g/L Agar to a Schott bottle which was 
autoclaved for 50 minutes, and left to cool to 50 ºC. Once cooled, 1 mL 
Cholesterol (5 mg/mL stock solubilised in ethanol) , 1 mL 1 M MgSO4, 25 mL 
1 M KH2PO4, 1mL 1 M CaCl2 and 1ml 2 mg/ml Uracil was added. NGM 
plates were seeded by spread plating 50µL of an overnight culture of E. coli 
OP50 and incubated overnight at 37ºC  to create bacterial lawns (Hartman et 
al., 1982, Williams et al., 1988). 
E. coli strains were routinely incubated overnight at 37 ºC in 5 mL lysogeny 
broth (LB) medium (Bertani et al., 1951) in 50 mL Falcon tubes (Greiner Bio-
One). Antibiotics were added at the following concentrations for fosmid 
maintenance; kan 50 µg/mL, Cm 12.5 µg/mL, and kan 150 µg/mL was used 
for selection of the miniTn5 transposon. Where appropriate, arabinose 2% (w / 
v) was added to induce the production of proteins from the Parabad promoter in 
the fosmid. 
 
 2.2 DNA extraction from fosmids and Agarose gel electrophoresis  
 
Fosmid DNA was extracted by initially culturing E.coli strains harbouring the 
fosmids in 4 mL of LB with Cm, Kan and L-arabinose in a 50mL falcon tube 
for 18 h at 200 rpm at 37
o
C. The overnight culture was used for the extraction 
of fosmids by using a Zippy™ Plasmid Miniprep Kit as per the manufacturer 
instructions, but with some minor modifications. Three mL of bacterial culture 
was centrifuged for 30 seconds at 16000 x g. After discarding the supernatant, 
600 μl of sterile milliQ was added to the bacterial cell pellet to completely re-
suspend it. After this, 350 μl of cold Neutralization Buffer was added and 
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mixed thoroughly until the samples turned yellow, indicating that the 
neutralization was completed. Tubes were centrifuged at 16000 x g for 4 min. 
The  supernatant was  transferred  into  the  Zimo-Spinn™  IIN  columns, and 
then placed into  a  Collection  Tube  and  centrifuged  for  30  sec.  The 
supernatant was then discarded and the column was transferred to a new 
Collection Tube. Two-hundred μL  of  Endo-Wash  Buffer  were  added  to  
the  column  and  centrifuged  for  30 sec, followed by the addition of 400μL 
Zippy™ Wash Buffer and centrifugation for 1 min. Finally, the column was 
placed in a sterile 1.5 mL micro-centrifuge tube, 30μL of Molecular Grade 
water was added directly to the column matrix, incubated for 4 min at 25 
o
C 
then centrifuged at max speed for 30 sec. DNA quantification was measured 
using a NanoDrop ND-1000 with NanoDrop v3.1.2 software by assessing the 
absorbance ratio at 260 and 280 nm. The  Fosmid  DNA  extracted  were  run  
on  0.1%  agarose  gel  in  1  x  TBE  buffer for 40 min at 120 V (Volt) and 
400 Mv (Millivolt), to determine the  approximate  size  of  the  fosmid  insert,  
and  to  determine  the  amount of DNA necessary for the sequencing. Two µL 
of each fosmid DNA were mixed with 2 µL of loading dye. EcoRI and HindIII 
digested ƛ DNA and 1kb DNA ladder were used as markers. After running, the 
gel was visualized on a Gel Doc 2000 UV trans-illuminator at 302 nm (Bio-
Rad).  
 Generation of a transposon mutant library  
 
Transposon mutagenesis was performed by using the EZ-Tn5™<T7/KAN-
2> Promoter insertion kit (Epicentre) according to the manufacturer‟s 
instructions. Briefly, 0.01 pmol fosmid DNA was combined with 0.01 pmol 
miniTn5 transposon and incubated for 2 h at 37 ºC. Electroporation was 
then used to introduce foreign DNA into bacterial strains using a Biorad 
Micropulser. Electrocompetent cells of E. coli were prepared according to 
Sambrook (1981) with all steps performed on ice. Briefly, cultures were 
grown in 100 mL SOB (Tryptone 20 g/L, yeast extract 5 g/L, NaCl 0.56 
g/L, KCl 0.17 g/L) in a 500 mL Erlenmeyer flask to an OD600=0.5 with 
incubation at 37 ºC  and shaking at 200 rpm. Cells were harvested by 
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centrifugation for 2 min at 10 000 × g at 2ºC  (Beckman Avanti J25-I) and 
washed twice in an equal volume of ice cold 10% glycerol (v / v), then were 
concentrated 20 fold in ice cold 10% glycerol and stored as 100 µL aliquots 
at -80 ºC. For electroporation, all steps were performed on ice including the 
use of pre-chilled disposable cuvettes (0.1 cm width, Biorad). Fosmid DNA 
(0.2 µg), was mixed with electrocompetent E. coli cells by gentle pipetting, 
and electroporation was achieved by a single pulse of 1.8 kV at 200 Ω and 
25 mF (Biorad micropulser). Samples were then immediately recovered in 1 
mL of LB, transferred to 15 mL Falcon tubes, grown for 1 h at 37°C with 
shaking at 200 rpm, and finally plated on to selective medium and incubated 
at 37°C overnight. The Tn5 transposon carries the kanamycin resistance 
cassette (kan
r
), and successful transposon insertion to the fosmid was 
indicated by growth in the presence of kan. Single colonies were then 
picked up from the selective plates, and inoculated in separate wells of a 96 
well plate in 200 µL LB supplemented with glycerol 30% (v / v), and grown 
overnight at 37
o
C with shaking at 200 rpm. Finally, the 96-well plates 
containing the E. coli transposon mutant libraries were stored at -80°C.  
 
3.2 Transposon library screening 
 
Initially, 96 individual bacterial clones from the JJ117 transposon mutant 
library were inoculated on solid agar plates, and subsequently L4 stage C. 
elegans was inoculated at defined locations throughout the plate. 
The 96 well plate frozen stocks were replicated on LB with the appropriate 
antibiotics and L-arabinose in rectangular petri dishes using a 96 pin 
replicating tool (Primorigen Biosciences, LLC). The medium was made with 
LB solid medium (1.5% agar (w/v)) containing 12.5 µg/mL Cm, 50 µg/mL 
kan and 0.2 % (w/v) L-arabinose, and incubated at 25°C for 48-72 hours (2-3 
days). 
Worms were used in the L4 stage of growth to ensure reproducibility and 
accuracy of the experiments. This was achieved by an initial synchronization 
of worm growth, where gravid adults were harvested from 4 d old NGM plates 
of C. elegans feeding on E. coli OP50 for the isolation of eggs. Gravid adults 
were collected by rinsing the plates with 10 mL of Milli-Q water (sterile 
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water), and transferred to 50 mL Falcon tubes containing 3 mL bleach and 1 
mL NaOH (0.5 M), and were shaken for 5 min. The loss of viability for adult 
worms was observed under a microscope, as was the release of eggs. To 
collect the eggs, these mixtures were centrifuged at 1800 rpm at 4°C for 3 min, 
the supernatant was aspirated, the pellet was resuspended in S basal medium, 
and this washing stage was repeated a total of three times. Following a final 
centrifugation and aspiration of the supernatant, the isolated eggs were 
transferred to NGM solid medium by pipetting and incubated at 25°C for 24 h 
to allow the worms to hatch and synchronise growth at the L1 stage in the 
absence of food. These synchronised worms were then transferred to NGM 
plates seeded with E.coli OP50 as a food source and incubated for 72h at 
25°C, and inspected by light microscopy to identify when the L4 stage of 
growth was reached. Worms in the L4 stage of growth were harvested by 
flooding the plates with sterile water and concentrated by allowing the worms 
to pellet by gravity following 5 min on ice. An average of 1000-2000 L4 stage 
worms were inoculated on rectangular NGM plates with bacterial colonies of 
the Tn mutant library (see above for details) by pipetting. Plates containing 
bacterial colonies and L4 stage worms were incubated at 25°C, and bacterial 
grazing was scored every day until all the colonies were completely grazed. 
The screening was repeated for three biological replicates.  
 
3.3 C.elegans toxicity test   
 
The bacterial clones (n=28) selected from the Transposon library screening 
were analysed by a toxicity test to confirm that they display altered toxicity 
towards C. elegans. Each mutant was picked up from the 96 well frozen stock 
with a loop and streaked on to LB solid medium (1.5 % agar (v/v)) 
supplemented with Cm and kan, and incubated at 37°C overnight. From these 
plates, a single colony was selected and inoculated in 5 mL of LB containing 
Cm and kan and incubated at 37°C with shaking at 200 rpm for 18 h. 
Following this incubation, small petri dishes (35mm x 10mm, D x H) 
containing LB, Cm, Kan and L-arabinose were spread with 20-30μl of the 
liquid culture. Experiments were performed in three biological replicates and 
the plates were kept at 25
o
C for 3 d. Following this, between 20 and 40 L4 
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stage worms (see section 1.2) were transferred to the plates. Variation  in  the  
worms‟  number  was  monitored  for  the  following  25  days.  The toxicity 
test was considered complete when more than 80% of the worms were 
deceased within 20 or 21 days. The toxicity of the selected clones were 
compared with the negative control EPI300, containing the fosmid 1A1 that is 
not toxic for the worms, and the toxic fosmid J117 that was used as a positive 
control. The survival of worms was then calculated by the Kaplan-Meier 
method (see below) and presented as % survival of worms over time. 
 
3.4 Transposon insertion mapping 
 
The transposon insertion mapping was sequenced bi-directionally for 18 
selected fosmids that displayed altered bioactivity using the FP1 Forward 
Primer  5 -ACCTACAACAAAGCTCTCATCAACC-3  and  P-1  everse 
Primer  5 -GCAATGTAACATCAGAGATTTTGAG-3  pair. Initially, PCR 
was used to amplify DNA flanking the transposon insertion site using 250 ng 
of fosmid DNA as a template in a reaction containing: 1 µL BigDye terminator 
V3.1, 3.2 pmol primer, 3.5 µL BigDye buffer and molecular water to a final 
volume of 20 µL.  
PCR was performed in a thermocycler as follows: an initial 95°C for five min, 
then 25 cycles of 96°C for 10 sec, 50°C for 5 sec, then samples were stored at 
4°C.  
Following PCR the DNA products were purified by ethanol/EDTA 
precipitation. Initially, 10 µL of molecular grade water and 5 µL of 125 mM 
EDTA was added to the PCR tubes, the entire mixture was transferred to a 1.5 
mL tube, and 70 µL of 95% ethanol was added. The tube was incubated for 15 
min at 25°C, centrifuged at 10 000 x g at 4°C for 30 min. The supernatant was 
discarded, 60 µL of 70% ethanol was added, centrifugation was repeated and 
finally the supernatant was discarded. The pellet containing the DNA was dried 
for 3 h in a dark room at 25°C. Sequencing was carried out by the Ramaciotti 
Centre at UNSW. The sequences of the 18 bacterial clones were aligned with 
the parental JJ117 fosmid to identify the location of fosmid insertions. Once 
identified, the ORF from JJ117 that was disrupted by the transposon was 
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submitted for analysis by the Basic Local Alignment Search Tool (BLAST) 
using the Integrated Microbial Genome (IMG) system as well as a conserved 
domain search using NCBI with the search for similar „somewhat similar 
sequences‟ function.  
4. Statistical Analysis  
Statistical significance of the data obtained from the toxicity test (section 3.3) 
was determined by using a two-tailed, non-paired Student‟s t-Test. Results 
were considered to be statistically significant if a p value scored <0.05. 
Survival curves were calculated according to the Kaplan-Meier method 
(Kaplan et al., 1958), using the equation; 
             
Where t = time (days), n = number of worms prior to t, and d = number of    
deaths. Data represents the cumulative percentage of worm survival over time 
(S).  
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Results 
 
1.2 Confirmation of fosmid toxicity  
Previous work had created a metagenomic library of the bacterial community 
of U. australis to aid in the identification of novel bioactive compounds (Egan 
et al., 2002; Egan et al., 2000). This work used fosmid clones containing 
random DNA to screen for toxicity towards the nematode C. elegans, and six 
toxic clones (jj29, jj30, jj55, jj71, jj83, jj117) were identified (Figure 3). 
To validate that the selected fosmids retained toxicity towards nematodes under 
the conditions used in this study, toxicity studies were conducted. These 
experiments revealed that each of the clones retained their toxicity towards 
C.elegans, as indicated by the reduced survival of worms in the presence of 
toxic fosmids compared to the EPI300 control strain which showed no toxicity 
towards the worms (Figure 3). The JJ117 fosmid was found to display the most 
rapid killing of worms when compared to the other toxic clones, and was 
therefore selected for further analysis.  
 
      
 
 Figure 3.Survival of the six clones jj29,jj117,jj71,jj83,jj55,jj30, EPI300 negative control and 10D3 
positive control against C. elegans. The average of triplicates of the nematode viability assay is graphed 
as a percentage survival over time (days). Comparing all the clones to the positive control 10D3, JJ117 
results still toxic and the most toxic one. The graph indicates the six clones that were toxic with 80-90% 
of the worms dead between the seven and nine days.      
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 5.2 Construction of Tn mutants by electroporation 
 
Transposon mutagenesis of the JJ117 fosmid (Figure 4) was used to identify 
the genetic elements that are required for nematocidal activity. The kan
r
 
miniTn5 transposon was inserted randomly in to JJ117 fosmid, and introduced 
in to the EPI300 strain of E. coli. One hundred and fifty colonies of kan 
resistant E. coli clones, indicating successful insertion of the miniTn5 
transposon, were observed from 100 µL of cells, indicating an efficiency of 
1.5 * 10
^3
 per µg DNA. Following collection of individual Tn mutants, there 
were 3 plates containing 96 mutants, which, assuming that each clone 
represents a unique single insertion in to the JJ117 fosmid, represents 288 
different mutations. Assuming that the 20 kb fosmid has an average gene of 1 
kb, it would contain 2 000 genes. The 288 Tn mutants would therefore display 
approximately 14% coverage of this fosmid (a Tn mutant in 14% of the fosmid 
genes).  
 
Table 1.List of Tn mutants selected after the screening for the toxicity assay and Tn mutants selected 
after toxicity assay for fosmid Dna extraction and sequencing (section 5.3-5.4).*For each Tn mutants 
there are 3*96 well plates cointaining 96 mutants.* Statistical significance was determined by using a 
two-tailed, non-paired Student‟s Test.  esults were statistically significant if a p value scored <0.05. 
Survival curves were calculated according to the Kaplan-Meier method (Kaplan et al., 1958), so all the 
mutants selected for the screening were statistically  significant.  
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5.3 Screening of the Transposon (Tn) mutant fosmid libraries for 
the loss of toxicity against C.elegans 
 
A high throughput approach was used to identify fosmid clones that contained 
Tn insertions which altered the bioactivity of the previously nematocidal JJ117 
fosmid. This involved plating 288 individual bacterial strains (3*96-plate 
replicators) harbouring the JJ117 transposon library on solid agar plates, and 
subsequently inoculating L4 stage C. elegans at defined locations throughout 
plates. Given that C. elegans consumes the least toxic food sources before the 
more toxic prey (Lewenza et al., 2014), some Tn mutants were consumed 
quickly by C. elegans, while others were not grazed until later (Figure 4.A). 
As expected, the EPI300 negative control was quickly consumed by the 
worms, while the positive and toxic control JJ117 was not consumed until all 
other food sources were exhausted. Therefore, the colonies that were 
preferentially grazed by C. elegans (28 mutants), indicating a potential loss of 
toxicity from the Tn insertion, were selected for further studies (Table 1).  
 
 
       
 
Figure 4 (A,B,C). Screening of the Transposon (Tn) mutant fosmid libraries for the loss of toxicity 
against C.elegans. The picture A and C, rapresent a bacterial clone potenzially toxic for C.elegans. The 
picture B, rapresent a bacterial clone potenzially no toxic, grazed by C.elegans. 
 
 
5.4 Toxicity test to confirm the loss of toxicity 
 
For each of the 28 mutants with altered grazing preference for C. elegans in 
the screening (table.1), a toxicity test was carried out to confirm that these 
clones display reduced toxicity. As expected, the EPI300 negative control 
A B C
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containing the fosmid 1A1 displayed the slowest killing of worms, consistent 
with its lack of toxicity. Also, the parental JJ117 fosmid positive control 
displayed the fastest killing of worms. These studies then revealed that each of 
the selected clones displayed a reduced toxicity towards C. elegans when 
compared to the positive control JJ117, but nine fosmid clones (2C6, 2F1, 
2H7, 2F5, 2G12, 2F6, 2G3, 2E10, 2E7), seleceted by the screening displayed 
toxicity, indicating that the screening is less accurate than the toxicity test. In 
fact the toxicity test, isolated 18 fosmid clones with altered bioactivity (Figure 
5 A, B, C, D, E, F, G). 
 
 
 
 
 
 
 
 
       A 
B 
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Figura 5 (A,B,C,D,E,F). Nematode viability assay of 3x grazed transposon mutants identified in section 
(5.3).The average of triplicates of the nematode viability assay is graphed as a percentage survival  over  
time  (days). 
 
 
 
 
E 
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5.4 Transposon mapping of selected fosmids with reduced 
bioactivity 
 
Following the successful identification of transposon insertions that altered 
bioactivity of the JJ117 fosmid, the location of these insertions was 
investigated.  I sequenced 18 bacterial strain clones that selected from the 
toxicity assay against C.elegans. Unfortunately, there were six bacterial clones 
(2D9, 2F4, 2C11, 2D5, 2E5,) that didn‟t give a good electropherogram for 
unknown reasons, and the location of the transposon was not identified for this 
reason. There were also 8 bacterial clones (2C5, 1B12, 4C11, 2D8, 2B8, 2D1, 
2E8, 2D3) that gave sequences that were not similar to the JJ117 fosmid, also 
for unknown reasons. Finally, there were also three bacterial clones (2D6, 
2C4, 2E6) that mapped to locations within the native fosmid rather than the 
DNA inserted from the metagenomic library. Nonetheless, the location of the 
transposon was successfully identified for the 2C7 clone. The JJ117 fosmid 
sequence, was disrupted by the transposon insertion and the transposon of 
clone 2C7 was mapped to one hypothetical ORF named as “2” in the genome 
map of JJ117 (966 bp), which is suspected to be responsible for the 
nematocidal activity. A BLASTn search (Figure 6) using the nucleotide 
sequence of this hypothetical ORF with the database of the publically available 
BLAST server , found the highest coverage and identity for hypothetical 
proteins of unknown function from Dinoroseobacter shibae DFL 12, 
Agrobacterium tumefaciens str. C58, Agrobacterium radiobacter K84, 
Roseobacter denitrificans OCh 114, Silicibacter sp. TM1040. Further analysis 
revealed that of the proteins with a conserved domain that are similar to gene 
„2‟ from JJ117, Martelella endophytica posseses a gene TM49_02190  with 
76% coverage and 68% identity to this ORF that a contains an α-helical 
domain with a conserved ER domain. Furthermore, Croceicoccus 
naphthovorans posseses a gene AB433_04100 with 43% coverage and 70% 
sequence identity to this ORF that possesses this same domain conformation.  
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Figure 6 Highest identity hits from a BLAST nucleotide search.. It‟s represented the corresponding 
analysis by BLASTn search, of the nucleotide sequence of the hypothetical ORF of JJ117 with the 
entire database, avaialable publically.This genetic element toxic against C.elegans may encode a 
protein displaying bioactivity. Identity (%) is the number of identical bases (bp) / the length of the 
alignment in question (bp). 
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Discussion 
 
This study aimed to identify and characterise novel bioactive compounds from 
the marine environment. Marine microorganisms are a source of structurally 
and biologically novel compounds with potential uses in the biotechnology 
and pharmaceutical industries. Most of the marine natural products have been 
isolated from organisms which live in the ocean, such as sponges, algae, corals 
and microorganisms. Marine microorganisms are a growing source of natural 
products with a 10 % increase in the number of compounds reported from 
2011 to 2012 (Blunt et al., 2012). One major challenge that is involved in the 
identification of novel bioactive compounds from natural environments is that 
the vast majority (> 99%) of microorganisms do not grow under laboratory 
conditions.  
This work shows that molecular biology techniques combined with toxicity 
screening with nematodes can successfully isolate the genetic determinants of 
novel bioactive compounds. Using the well characterised bacterium E. coli for 
heterologous expression of DNA derived from seaweed associated bacterial 
communities allowed for the testing of environmental DNA that would 
otherwise be inaccessible to study in the laboratory. Compared with terrestrial 
ecosystems, marine bacterial isolates are not well explored and only a limited 
number have been reported as being producers of bioactive compounds.    
 
 
1. Nematocidal activity 
 
In this study we isolated clones with potentially novel bioactive compound/s 
by testing DNA derived from marine environments for differences in toxicity 
towards nematodes. To achieve this, we used the nematode C. elegans as a 
model organism. This model organism has been well characterised as a proxy 
for bacterial and fungal pathogenesis, for neurological studies, and studies of 
aging (Spradling et al., 2006). Recent studies of surface associated marine 
bacteria have led to the hypothesis that a range of inhibitory bioactive 
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compounds are used to compete for nutrients and space, and for protection 
against predators (Frank et al., 2005; Matz et al., 2008).  
Previous work had isolated bacterial DNA from the seaweed U. australis and 
identified some genetic elements displaying bioactivity when expressed in the 
heterologous E. coli host. The study presented here found that the jj29, jj30, 
jj55, jj71, jj83, jj117 clones of bacteria harbouring DNA from seaweed 
associated microbiota displayed toxicity towards C. elegans. While all of these 
genetic elements are potential candidates for encoding novel bioactives, we 
selected the most toxic clone JJ117 for further analysis. The fosmid JJ117 
comes from a metagenomic library performed on the entire epiphytic 
microbial community of U. australis.  
This clone contains an insert of DNA that contains multiple reading frames, 
and we next sought to identify the specific components of this DNA that are 
required for the observed nematocidal activity. A random transposon mutant 
library of JJ117 was then obtained and screened for a loss of toxicity towards 
C. elegans. However, the initial screening was not entirely conclusive because 
C. elegans had the possibility to choose different food sources, and the loss of 
toxicity was implied by the preferential grazing behaviour of C. elegans rather 
than directly testing the levels of toxicity. The loss of nematocidal activity for 
the 18 selected clones was therefore confirmed by using a toxicity assay. 
Finally, these experiments found that each of the clones selected from the 
screening did in fact show a reduced toxicity towards the worms.  
Therefore, Tn-sequencing was carried out in order to identify the specific 
location of the Tn and hence the specific genetic elements in the clones 
responsible for the toxic activity. Unfortunately there were six bacterial clones 
(2D9, 2F4, 2C11, 2D5, 2E5, 2D4) that didn‟t give a good electropherogram for 
unknown reasons. There are many potential reasons for this observation, 
including the binding of the primer to multiple locations on the DNA template.  
There were also 8 bacterial clones (2C5, 1B12, 4C11, 2D8, 2B8, 2D1, 2E8, 
2D3) that gave sequences that were not similar to the JJ117 fosmid, also for 
unknown reasons.  
Finally, there were also three bacterial clones (2D6, 2C4, 2E6) that mapped to 
locations within the native fosmid rather than the DNA inserted from the 
metagenomic library. The fosmid serves as the vector for expression of the 
 33 
 
heterologous DNA, and insertion of the Tn within the fosmid backbone could 
potentially limit the expression of the insert DNA and cause the observed 
reduction in toxicity. This could plausibly occur by reducing the stable copy 
number of the fosmid or the levels of transcription of the insert DNA. Further 
analysis of the locations within the fosmid backbone that were disrupted by the 
Tn insertions are required to make more accurate predictions about the nature 
of the reduced toxicity. 
Interestingly, the Tn insertion was mapped to an ORF with unknown function 
for the 2C7 bacterial clone with attenuated toxicity. This indicated that the 
transposon is located within and disrupted the function of the DNA encoding 
bioactivity of the nematocidal compound. Sequencing of this clone revealed 
that the transposon was located within the gene “2” of the DNA sequence of 
JJ117 (966 bp).  
The gene that was disrupted for clone 2C7 was found possess the highest 
similarity with many genes from diverse bacteria that did not contain any 
functional predictions. Nonetheless, O F „2‟ was found to display 76% 
coverage and 68% sequence identity with the TM49_02190 gene from 
Martelella endophytica. This gene harbors a conserved ER motif, and is 
annotated as a circularly permutated ATP grasp-domain containing protein. 
Interestingly, the TM49_02190 has previously been implicated in the synthesis 
of complex secondary metabolities, including diverse antibiotics 
(Lakshminarayan et al., 2009). Furthermore, the gene “2” that was disrupted 
for clone 2C7 was found to display 43% coverage and 70% sequence identity 
with the AB433_04100 gene from Croceicoccus naphthovorans. This gene 
harbors an α-helical conserved, and is annotated as a circularly permutated 
ATP grasp-domain containing protein. This gene (AB433_04100) has 
previously been implicated in the synthesis of complex secondary 
metabolities, including diverse antibiotics. While further experiments are 
required to confirm this hypothesis, this intriguing result suggests that O F „2‟ 
could be involved in the production of a novel secondary metabolite and 
bioactive compound. 
As such, the disruption of „gene 2‟ in fosmid JJ117 could have caused a 
reduction in toxicity of this clone by disrupting the putative (details of function 
as described above) activity of this protein. 
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Table 2: ATP-grasp amidoligases systems and their functional partners. 
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Conclusions 
 
This study initially quantified the toxicity of six environmental DNA clones 
towards the model organism C. elegans, allowing the identification of the most 
toxic clone (JJ117) which was selected for further analysis. Next, random Tn 
mutagenesis of JJ117 and library screening for altered toxicity towards 
nematodes was combined to identify the genetic basis for the toxicity of JJ117. 
This analsys identified the clone 2C7 to display the most altered nematocidal 
activity, implying that the transposon is located within and disrupted the 
function of the DNA encoding bioactivity of the nematocidal compound. 
Sequencing of this clone revealed that the transposon was located within the 
„O F “2” sequence of JJ117. Through a preliminary bioinformatics analysis 
by NCBI BLASTn, this study shows that this genetic element  O F “2”  that 
was disrupted from the bacterial clone 2C7, was found to display 76% 
coverage and 68% sequence identity with the TM49_02190 gene from 
Martelella endophytica and a 43% coverage and 70% sequence identity with 
the AB433_04100 gene from Croceicoccus naphthovorans. 
Each of these have previously been implicated in the synthesis of complex 
secondary metabolities, including diverse antibiotics (Table 2), providing a 
potential link between the suspected toxic nature of gene „2‟ from JJ117 and 
the production of secondary metabolites with bioactive properties.  
 
 
 
 
 
 
 36 
 
References 
Andrew K. Jones, Steven D. Buckingham & David B. Sattelle (2005) 
Chemistry-to- gene screens in Caenorhabditis elegans. Nature Reviews Drug 
Discovery 4, 321-330| doi:10.1038/nrd1692. 
 
Angstadt, J.D., Donmoyer, J.E., and Stretton, A.O. (1989). Retrovesicular 
ganglion of the nematode Ascaris. J.Comp. Neurol. 284, 374–388. 
 
Ballestriero, F., Daim,M., Anahit P., Nappi,J., David S.,Paolo B., Elia Di S., 
Egan, S., (2014). Antinematode Activity of Violacein and the Role of the 
Insulin/IGF-1 Pathway in Controlling Violacein Sensitivity in Caenorhabditis 
elegans. PLoS ONE 9(10): e109201. doi:10.1371/journal.pone.0109201. 
 
Ballestriero, F., Thomas, T.,Burke, C., Egan, S., Kjelleberg, S., (2010) 
Identification of Compounds with Bioactivity against the Nematode 
Caenorhabditis elegans by a Screen Based on the Functional Genomics of the 
Marine Bacterium Pseudoalteromonas tunicata D2†. Applied and 
Environmental Microbiology, Sept. 2010, p. 5710–5717. 
 
Bertani.G., (1952) Studies on lysogenesis. I. The mode of phage liberation by 
lysogenic Escherichia coli. PubMed,NCBI. 
 
Bhatnagar, I., Kim, S.E., (2010) Immense Essence of Excellence: Marine 
Microbial Bioactive Compound. Mar.Drugs 2010,8,2673-2701; 
doi:10.3390/md 8102673. 
 
Biebl, H., Allgaier, M., Tindall, B.J., Koblizek, M., Lu¨nsdorf,Ru¨diger Pukall, 
H., Wagner-Do¨bler, I., (2005) Dinoroseobacter shibae gen. nov., sp. nov., a 
new aerobic phototrophic bacterium isolated from dinoflagellates. 
International Journal of Systematic and Evolutionary Microbiology (2005), 55, 
1089–1096. 
 37 
 
Blaxter, M., 1998 Caenorhabditis elegans is a nematode. Science 282: 2041-
2046. 
 
Blunt ,J., Buckingha, J., Munro,M.,(2012) Taxonomy and Marine Natural 
Products Research. Handbook of Marine Natural Products pp 3-54. 
 
Blunt, J.W., Copp, B.R., Munro, M.H.G., Northcote, P.T., Prinsep, M.R., 
(2005) Marine natural products. Review, NPR, www.rsc.org/npr. 
 
Boyd, K.G., Adams, D.R. and Burgess, J.G. (1999) Antibacterial and repellent 
activities of marine bacteria associated with algal surfaces. Biofouling, 14, 
227-236. 
 
Bourlat, S. J., C. Nielsen, A. D. Economou, and M. J. Telford, 2008 Testing 
the new animal phylogeny: a phylum level molecular analysis of the animal 
kingdom. Mol. Phylogenet. Evol. 49: 23-31. 
 
Bowman,J.P., (2007) Bioactive Compound Synthetic Capacity and Ecological 
Significance of Marine Bacterial Genus Pseudoalteromonas. Mar. Drugs 2007, 
5, 220-241. 
 
Breger, J., Burgwyn Fuchs, B., Aperis, G., I. Moy, T., M. Ausubel, F., 
Mylonakis, E., (2007) Antifungal Chemical Compounds Identified Using a 
C.elegans Pathogenicity Assay. PLoS Pathog 3(2):e18. 
doi:10.1371/journal.ppat.0030018. 
 
Buchan,A., Gonza´lez,J.M., Moran,M.A.,(2005) Overview ofthe Marine 
Roseobacter Lineage†. Applied and Environmental Microbiology, Oct. 2005, 
p. 5665–5677. 
 
Das,S., Lyla P.S., Khan,S.A., (2006) Marine microbial diversity and ecology: 
importance and future perspectives. Current Science, VOL. 90, NO. 10. 
 
 
 38 
 
Dittami, S.M., Eveillard, D., Tonon ., T., (2014) A metabolic approach to 
study algal–bacterial interactions in changing environments. Molecular 
Ecology (2014)23, 1656–1660. 
 
Egan, S., Fernandes, N.D., Kumar, V., Gardiner,M., Thomas, T.,(2014) 
Bacterial pathogens, virulence mechanism and host defence in marine 
macroalgae. Environmental Microbiology (2014)16(4), 925–938. 
 
Sarah E. M., Petra C. F. Oyston (2008) Structure and function of the LysR-
type transcriptional regulator (LTTR) family proteins. Microbiology, 
Review154, 3609 3623.Gulder, T.A.M., Moore, B.S.,(2009) Chasing the 
treasures of the sea bacterial marine natural products. Current Opinion in 
Microbiology 2009,12:252–260. 
 
Geary T.G., and Thompson, D.P. (2001).  Caenorhabditis elegans: how good a 
model for veterinary parasites? Vet. Parasitol. 101, 371–386. 
 
Gwendowlyn S. Knapp, James C. Hu (2010) Specificity of the E. coli LysR-
Type Transcriptional Regulators. PLoS ONE 5(12): e15189. 
doi:10.1371/journal.pone.0015189. 
 
Hala A. Iqbal, Jeffrey W. Craig & Sean F. (2014) Antibacterial enzymes from 
the functional screening of metagenomic libraries hosted in Ralstonia 
metallidurans. Brady Laboratory of Genetically Encoded Small Molecules, 
Howard Hughes Medical Institute, The Rockefeller University, New York, 
NY, USA. 
 
Handelsman,j.,(2004) Uncultured Microorganisms Metagenomics: Application 
of Genomics to Uncultured Microorganisms. Microbiol.Mol.Biol.Rev. 
 
Harrington, A.J., Hamamichi, S., Caldwell, G.A., Caldwell,K.A., (2009) C. 
elegans as a Model Organism to Investigate Molecular Pathways Involved 
with Parkinson‟s Disease. Inter Science  www.interscience.wiley.com). 
 
 39 
 
Hellberg, J.E.E.U., Matilla, M.A., Salmond, G.P.C., (2015) The broad-
spectrum antibiotic, zeamine, kills the nematode worm Caenorhabditis 
elegans. Original Research article, frontiers in plant science.  
 
Holden-Dye, L., Crisford, A., Welz, C., von Samson-Himmelstjerna, G., 
Walker,  .J., and O‟Connor, V.  2012 .Worms take the slo lane: a perspective 
on the mode of action of emodepside. Invert. Neurosci. 12, 29-36. 
 
Holden-Dye, L. and R. J. Walker, 2014 Anthelmintic drugs and nematicides: 
studies in Caenorhabditis elegans (December 16, 2014), WormBook, ed. The 
C. elegans Research Community, WormBook,doi/10.1895/wormbook.1.143.2, 
 
Hui Luo, Jing Xiong, Qiaoni Zhou, Liqiu Xia, Ziquan Yu (2013) The effects 
of Bacillus thuringiensis Cry6A on the survival, growth, reproduction, 
locomotion, and behavioral response of Caenorhabditis elegans. 
 
Jones A.K, Buckingham S.D, Sattelle D.B.,(2005) Chemistry-to-gene screens 
in Caenorhabditis elegans. Nat Rev Drug Discov 4: 321–330. 
 
Johnson, S.C., Browman, H.I., (2007) Introducing genomics, proteomics and 
metabolomics in marine ecology. Marine Ecology Progress Series Vol. 332: 
247–248, 2007. 
 
Jung, H.E., Lim , Y., Kim, E.U., (2014) Therapeutic Phytogenic Compounds 
for Obesity and Diabetes. Int. J. Mol. Sci. 2014, 15, 21505-21537; 
doi:10.3390/ijms151121505. 
 
Kaletta,T., Hengartner,M.O., (2006) Finding function in novel targets: 
C.elegans as a model organism. Nature Reviews Drug Discovery 5, 387-399 
(May 2006). 
 
 
 40 
 
Kiontke, K. and D. H. A. Fitch, 2005 The Phylogenetic relationships of 
Caenorhabditis and other rhabditids (August 11, 2005), WormBook, ed.The 
C. elegans Research Community. 
 
Kudo F, Eguchi T. Methods in enzymology. 2009; 459:493–519. [PubMed: 
19362652 
 
L.Rosa., B.Peter., Factors that influence the response of the LysR type 
transcriptional regulators to aromatic compounds (2011). Lönneborg and 
Brzezinski BMC Biochemistry http://www.biomedcentral.com/1471-
2091/12/49. 
 
Lakshminarayan M. Iyer, Saraswathi Abhiman, A. Maxwell Burroughs,  L. 
Aravind (2009). Amidoligases with ATP-grasp, glutamine synthetase-like and 
acetyltransferase-like domains: synthesis of novel metabolites and peptide 
modifications of proteins. NIH Public Access Author Manuscript Mol Biosyst. 
Author manuscript; available in PMC 2012 January 29. 
 
Lewenza, S.,Charron-Mazenod, L., Giroux, L., Zamponi, A.D., (2014) 
Feeding behaviour of Caenorhabditis elegans is an indicator of Pseudomonas 
aeruginosa PAO1 virulence. PeerJ. 2014; 2: e521. 
 
Llewellyn NM, Li Y, Spencer JB. Chemistry & biology. 2007; 14:379–386. 
[PubMed: 17462573]. 
 
Maxwell C. K. Leung, Phillip L. Williams, Alexandre B.,Catherine Au, 
Kirsten J. Helmcke, Michael A., Joel N. Meyer., (2008). Caenorhabditis 
elegans: An Emerging Model in Biomedical and Environmental Toxicology. 
Toxicological Sciences 106(1), 5–28 (2008) doi:10.1093/toxsci/kfn121. 
 
Martha M., Maria O., (2014). In situ Chemotaxis Assay in Caenorhabditis 
elegans (for the Study of Circadian Rhythms). http://www.bio-
protocol.org/e1040 Vol 4, Iss 3, Feb 05, 2014. 
 
 41 
 
Martin, J. ., Harrington, C., Dobson, A.D.W., O‟Gara,F., (2014) Emerging 
Strategies and Integrated Systems Microbiology Technologies for 
Biodiscovery of Marine Bioactive Compounds. Mar. Drugs 2014, 12, 3516-
3559; doi:10.3390/md12063516. 
 
Marwa.D., Hamann.M.T., (2013) Marine natural products and their potential 
applications as anti-infective agents. The lancet Infectious Diseases Vol 3 June 
2003. 
 
Maupas E. Modes et formes de reproduction des nematodes. Archives de 
Zoologie Experimentale et Generale. 1900;8:463–624. 
 
Neu, A.K., Månsson, M., Gram, L., Prol-Garcíaa,M.J., (2015) Toxicity of 
Bioactive and Probiotic Marine Bacteria and Their Secondary Metabolites in 
Artemia sp. and Caenorhabditis elegans as Eukaryotic Model Organisms. 
AEM, journals.ASM.org. 
 
Penesyan,A.,Ballestriero,F.,Daim,M.,Kjelleberg,S.,Thomas,T.,Egan,S., (2013) 
Assessing the Effectiveness of Functional Genetic Screens for the 
Identification of Bioactive Metabolites. Mar. Drugs 2013, 11, 40-49; 
doi:10.3390/md11010040. 
 
Penesyan, A., Marshall-Jones, Z., Holmstrom,C., Kjelleberg,S., Egan.S., 
(2009) Antimicrobial activity observed among cultured marine epiphytic 
bacteria rejects their potential as a source of new drugs. FEMS. 
 
Penesyan,A., Kjelleberg,S., Egan, S., (2010) Development of Novel Drugs 
from Marine Surface Associated Microorganisms. Mar Drugs. 2010; 8(3): 
438–459. 
 
Sabree, Z.L., Rondon, M.R., Handelsman,J., (2009) Metagenomics. University 
of Wisconsin-Madison, Madison, WI, USA. 
 
 42 
 
Sasakura,H., Mori, I., (2013) Behavioral  plasticity,  learning,  and  memory  
in  C.  elegans. Current  Opinion  in  Neurobiology  2013,  23:92–99. 
 
Sifri C.D., Begun J., Ausubel F.M., (2005) The worm has turned-microbial 
virulence modeled in Caenorhabditis elegans. Trends Microbiol 13: 119 
127.“C.elegans a pratical approach”. Book Edited by IAN A. HOPE. 
 
Spradling, A., Ganetsky, B., Hieter, P., Johnston,M., Olson, M., Orr-Weaver, 
M.T., Rossant, J., Sanchez, A., Waterston,R., (2006) New Roles for Model 
Genetic Organisms in Understanding and Treating Human Disease: Report 
From The 2006 Genetics Society of America Meeting. Genetics. 2006 Apr; 
172(4): 2025–2032. 
 
Surajit Das, P. S. Lyla, S. Ajmal Khan (2006) Marine microbial diversity and 
ecology: importance and future perspectives. Current science,Vol.90,NO.10,25 
May 2006. 
 
Tabata K, Ikeda H, Hashimoto S. Journal of bacteriology. 2005; 187:5195–
5202. [PubMed:16030213]. 
 
Torsten,T., Rusch, D., DeMaere, M.Z., Yung, P.Y., Lewis, M.,Halpern, A., 
Heidelberg, K.B., Egan, S., Steinberg, P.D., Kjelleberg,S. (2010) Functional 
genomic signatures of sponge bacteria reveal unique and shared features of 
symbiosis. The ISME Journal (2010) 4,1557–1567. 
 
Wichard, T., Charrier, B.,  Mineur, F., H. Bothwell, J., De Clerck, O.,  C. 
Coates, J.,(2015) The green seaweed Ulva: a model system to study 
morphogenesis. Mini review article, frontiers in plant science. 
 
Wietz, M., Duncan,K., Patin,N.V., Jensen,P.R., (2013) Antagonistic 
Interactions Mediated by Marine Bacteria: The Role of Small Molecules. 
Article in journal of chemical ecology. 
 
 43 
 
Zozaya-Valdes, E., Egan,S., Thomas,T., (2015) A comprehensive analysis of 
the microbial communities of healthy and diseased marine macroalgae and the 
detection of known and potential bacterial pathogens. Original Research 
article, frontiers in Microbiology. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 44 
 
Appendix 
 
LB10 (Lysogeny-Broth media) 
Tryptone 10 g 
Yeast extract 5 g 
Sodium chloride 10 g 
Sterile MilliQ water 1 L 
Sterilize by autoclaving.  For solid media is required 20 g of bacteriological 
agar is added before autoclaving. 
 
SOC media 
Tryptone 20 g 
Yeast extract 5 g 
Sodium chloride 0.5 g 
Potassium chloride (250 mM) 10 mL 
Sterile MilliQ water 
After autoclaving add: 
Glucose (1 M) 20 mL 
 
S. Basal 
K2HPO4(0.05 M) 129 mL 
KH2PO4(0.05 M) 871 mL 
Sodium chloride 5.85 g 
Cholesterol 5 mg 
Sterilize by autoclaving 
 
1X TE Buffer 
Tris-HCl (1 M, pH 8) 1 mL 
Ethylenediaminetetraacetic acid (EDTA) (0.5 M) 0.2 mL 
MilliQ water 988 mL. 
 
DNA marker used 
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Primer transposon-specific the EZ-Tn5TM<T7/ KAN-2>  (Epicentre) 
 
FO WA D 5 ACCTACAACAAAGCTCTCATCAACC - 3  
 EVE SE 5 - GCAATGTAACATCAGAGATTTTGAG - 3  
 
Nematode lysing mixture 
Super strength bleach 3 mL 
Sodium hydroxide (5 M) 1 mL 
Sterile MilliQ water 5 Ml 
 
SOC media 
Tryptone 20 g 
Yeast extract 5 g 
Sodium chloride 0.5 g 
Potassium chloride (250 mM) 10 mL 
Sterile MilliQ water 
After autoclaving add: 
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Glucose (1 M) 20 mL 
 
Gene sequence (1720 bp), localized in the DNA sequence of JJ117, 
hypothesized to be responsible for the antinematode activity.  
&gt;BASYS00002 BASYS00002, 1543-2508 (Clockwise)  
 
TTGGGTCTTGGAGGAGTAACGCACATGCTCGGAAAAACTGCAGGCGGCCTTTATT
GGATGTTTCGCTATTTGGAGCGCAGTGAGAACATCACGCGGATGATTGATGTCGG
TTTGCGCATTTCGCTCACGCGGCCAGATAATGCACAGGATGAATGGGCGTCTATC
ATGGACAGCGCAGGGGTGCGCTCGATCTATGAAGAAACCCATGACAAGGTGAAC
GCAGCGAGTGTCATAGATTTTTTACTCCGCGATCCAGACAATCCGTCGAGCGTGAT
GTCCTGTATTGGTTCTGCACGCATGAATGCCCGGCTCGTTCGGACGGCGCTGACCC
GCGAGGTGTGGGAAGCGACGAATGAATGTTGGTTGCGGCTGAAGGATGTGCTGGC
GGAACCCGTGGCGGCGCGAGAGCTGCCAGAGGTGCTGGGCATTATCCGACAGCA
AAGCGCCTTGGTCCGCGCCGCGCTTCACGGAACGATGCTGCGAAACGAGATTTAC
AACTTCTCGCGCATTGGCACATTCATCGAGCGTGCAGACAACACCGCGCGTATCC
TCGACGTGAAATATTACGTCCTATTGCCGACGGCCAACCATGTCGGATCATCGCTC
GACAATGTGCAGTGGGAGACGATCTTGCGGTCGGCTTCGGGGTTCCGGTCCTATC
GGATGAATTATGGTCCTGACATAACCCCGCGCGGGATTGCCGAGTTCCTGATTTTT
GACCGTCAGATGCCCCGCTCGCTCGCGTTCTGTTATAGTAAGATCGGTGAGAACTT
AGGCTATCTGGAAGAGGGTCGCGCAGAGCGCCTACCGTCCAACGATGTCCACGAT
ATTTTCCGACGCGACTTCGAAACACAAAGCGTCGATACGATTTTTGATCTCGGGCT
GCACACCTTCCTGCGCGGCTTTGAGGCGTATAACAGCAGGCTCGGTTCGCAGATT
GAGCAGGATTACAGGTTCCATAGCTAA. 
 
FORWARD Sequence of the mutant 2C7  
TAAATTCCCGAAAAATTTAAATACGACTCACTATAGGGAGACCGGCCTCAGGGTT
GAGATGTGTATAAGAGACAGGGGGTGCGCTCGATCTATGAAGAAACCCATGACA
AGGTGAACGCAGCGAGTGTCATAGATTTTTTACTCCGCGATCCAGACAATCCGTC
GAGCGTGATGTCCTGTATTGGTTCTGCACGCATGAATGCCCGGCTCGTTCGGACGG
CGCTGACCCGCGAGGTGTGGGAAGCGACGAATGAATGTTGGTTGCGGCTGAAGG
ATGTGCTGGCGGAACCCGTGGCGGCGCGAGAGCTGCCAGAGGTGCTGGGCATTAT
CCGACAGCAAAGCGCCTTGGTCCGCGCCGCGCTTCACGGAACGATGCTGCGAAAC
GAGATTTACAACTTCTCGCGCATTGGCACATTCATCGAGCGTGCAGACAACACCG
CGCGTATCCTCGACGTGAAATATTACGTCCTATTGCCGACGGCCAACCATGTCGG
ATCATCGCTCGACAATGTGCAGTGGGAGACGATCTTGCGGTCGGCTTCGGGGTTC
CGGTCCTATCGGATGAATTATGGTCCTGACATAACCCCGCGCGGGATTGCCGAGT
TCCTGATTTTTGACCGTCAGATGCCCCGCTCGCTCGCGTTCTGTTATAGTAAGATC
GGTGAGAACTTAGGCTATCTGGAAGAGGGTCGCGCAGAGCGCCTACCGTCCAACG
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ATGTCCACGATATTTTCCGACGCGACTTCGAAACACAAAGCGTCGATACGATTTTT
GATCTCGGGCTGCACACCTTCCTGCGCGGCTTTGAGGCGTATAACAGCAGGCTCG
GTTCGCAGATTGAGCAGGATTACAGGTTCCATAGCTAATCATGAACTGACATCAG
TCACCGGACAGATATCATTACGACACTCCGCCATCCTATGGATTGCAAAGGTACG
CCTTTGGGCTCGTTCGGGTCCGGACATCGGTTGGTGTCTGGGATTGTGAGCTAATG
GAGGGTTGCAAGCCCGCGGAGGCGGAGTATAAAGGACCACCAACGGGCCAACTG
GTCGCTCTGACAGGTCCTCATTCGGATCAAACATTGTCTCGATTCACTGTAGGGCG
TATCGACTAGGTATCTGGGCGTGGCTCGCAAGCATCGACTATGGCCCGATGGACT
GGTCCGTCAACTTGCTGCATACGTCATGGATCAG 
 
REVERSE sequence of the mutant 2C7 
 
TCCGGTGTGGGAAGGGATGGTAAGAGGGTTTAGGATGGACGCGGGCACCGCTGC
GCGGTCCGTGATAGACGCCATTAAAGAAAGGGCATTATCTGGCCGCGTGAGCGAA
ATGCGCAAACCTACATCAATCATCCGCGTGATGTTCTCACTGCGCTCCAAATAGCG
AAACATCCAATAAAGGCCGCCTGCAGTTTTTCCGAGCATGTGCGTTACTCCTCCAA
GACCCAAGTGTCCTTGGTCCCGCCGCCCTGACTGGAATTGACCACAAGAGAGCCT
TCCTTGAGCGCAACGCGTGTGAGGCCGCCGGGAGTAATCTCGATGCCCTTCGGCG
AAACGCGCACATAGGGCCGCAGATCCACATGGCGCGGAGCCAGTCCTTTTTTCGT
CAGGATCGGAACCGTCGACAGTGCCAGCGTCGGCTGAGCGATATAATTCGACGGA
CGTGCGCGCAGTTTGTCTGCAAAATCGGACAGCTCGCGCTTACTCGCGGCAGGGC
CAACCAACATGCCGTAACCGCCCGACCCGTGAACCTCTTTCACCACAAGCTCAGC
CAGATTATCCAGCACATAGGCCAGCGAGTCCGCCTCTGAACATCGCCATGTCGGC
ACGTTTTTGAGGATTGGTTTTTCGCCAGTATAAAACTCCACAATCGTCGGCATGTA
CGAGTAGAGCGCCTTATCATCCGAAATCCCGGTTCCCCGGCGCATTGGCAATGGT
GATGCCGCCAGAACGATAGACATCCCATGATCCCCGGTACACCCAACAGCGAGTC
TGGGTTGAATGTCAGCGGGTCAAGAAAATCGTCATCAATCTCGGCGATAGAGCAC
ATCAATCGGGTTGTAGCCGCGCGTCGTGCGCATCGCGACCCGGGCCATTCTTCGAT
CCCGCAGGTCGTGGCCCCTCGACCAAGCTTCTACGCCTCATCTCATCCGGCCAGAA
TTGATTGCTCAAAATACCGCGGAGTTATGGGATGCCAAGCGTGGAAAACAGCAAC
GAACAGGGCTGGCCCTCCACAGCTCTGGGGGCTGGCTGCGCGTAGCGGAGGCGCC
GCAAACCTTTTGGAATATCCAACTGAACGGGACGCAACCGCGGTACCGGCAAAAG
CTCTAGGGAACCATGTGCACGCATGGGTTTCCGGTTTCCGGCATGTATAGACCACC
CTGGAACGGGTGGCGGCGCATTTGTTCTCTA 
EZ-Tn5™<T7/KAN-2> Sequence DNA transposon (1248 bp). (EZ-Tn5™ 
<T7/KAN-2> Promoter Insertion Kit) 
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CTGTCTCTTATACACATCTCAACCATCATCGATGAATTGTGTCTCAAAATCTCTGATGTTA
CATTGCACAAGATAAAAATATATCATCATGAACAATAAAACTGTCTGCTTACATAAACA
GTAATACAAGGGGTGTTATGAGCCATATTCAACGGGAAACGTCTTGCTCGAGGCCGCGA
TTAAATTCCAACATGGATGCTGATTTATATGGGTATAAATGGGCTCGCGATAATGTCGGG
CAATCAGGTGCGACAATCTATCGATTGTATGGGAAGCCCGATGCGCCAGAGTTGTTTCTG
AAACATGGCAAAGGTAGCGTTGCCAATGATGTTACAGATGAGATGGTCAGACTAAACTG
GCTGACGGAATTTATGCCTCTTCCGACCATCAAGCATTTTATCCGTACTCCTGATGATGC
ATGGTTACTCACCACTGCGATCCCCGGAAAAACAGCATTCCAGGTATTAGAAGAATATC
CTGATTCAGGTGAAAATATTGTTGATGCGCTGGCAGTGTTCCTGCGCCGGTTGCATTCGA
TTCCTGTTTGTAATTGTCCTTTTAACAGCGATCGCGTATTTCGTCTCGCTCAGGCGCAATC
ACGAATGAATAACGGTTTGGTTGATGCGAGTGATTTTGATGACGAGCGTAATGGCTGGC
CTGTTGAACAAGTCTGGAAAGAAATGCATAAACTTTTGCCATTCTCACCGGATTCAGTCG
TCACTCATGGTGATTTCTCACTTGATAACCTTATTTTTGACGAGGGGAAATTAATAGGTT
GTATTGATGTTGGACGAGTCGGAATCGCAGACCGATACCAGGATCTTGCCATCCTATGG
AACTGCCTCGGTGAGTTTTCTCCTTCATTACAGAAACGGCTTTTTCAAAAATATGGTATT
GATAATCCTGATATGAATAAATTGCAGTTTCATTTGATGCTCGATGAGTTTTTCTAATCA
GAATTGGTTAATTGGTTGTAACACTGGCAGAGCATTACGCTGACTTGACGGGACGGCGG
CTTTGTTGAATAAATCGAACTTTTGCTGAGTTGAAGGATCAGATCACGCATCTTCCCGAC
AACGCAGACCGTTCCGTGGCAAAGCAAAAGTTCAAAATCACCAACTGGTCCACCTACAA
CAAAGCTCTCATCAACCGTGGCGGGGATCCTCTAGAGTCAACCTGGCTTATCGAAATTA
ATACGACTCACTATAGGGAGACCGGCCTCAGGGTTGAGATGTGTATAAGAGACAGBLA
STn between JJ117 Wild Type (Query) and 2C7 mutant (Forward and Reverse 
Sequences). 
 
 Forward  
Region of the   EZ-Tn5™<T7/KAN-2 transposon 
 
 
 Reverse 
Region of the   EZ-Tn5™<T7/KAN-2 transposon 
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CopyControlTM Fosmid Vector (Epicentre)  
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Organism      Croceicoccus naphthovorans 
AA sequence (314 aa): AB433_04100 A alpha-helical domain with a conserved 
ER moti. 
 
MLGRSANAIFWMFRYLERAENLARLLDTGFRMALTRDHLTAEEEWRSVIET
AGMRHGYAAQNGTYAGIQVWNYILRDRDNPNSIRSLIGAVRSNARSARNSI
TTELWEAVNESYLQLNDLLARPVTQSGLADAINTVKRESTLVRGAMDGSM
LRNDIYNFARIGSFVERADNTARIIDVKYYVLLPSLSYVGSSLDNVQWETILR
SLGAERAYRWLNAGQLDARGIANFLILDGQFPRSLRFCYAKIRSNLHNLALQ
YGEKLSSNEAMRKADLNLQDKDIDAVLEQGLHEFLSDFIADTHDIATAVET
DYRFTD 
 
Organism         Martelella endophytica 
 
AA sequence (312 aa): TM49_02190 A alpha-helical domain with a conserved 
ER moti. 
MLGKTANGLYWMFRYIERAENIARLIDAGQRVSLTRSKGADDWDGILQS
AGVHEAFYEIYSKLTADSAIDFLLRDRRNPSSVMSCIESGRNNARLVRTAL
TRETWEATNECWIEARAMLAAKLKPADLPKAIDSVKRCTALIRGTFHGS
MLRNEIYNFAHIGTFVERADNTSRILDVKYYVLLPSVHHVGTSLDNLQWE
SILRSVSAHRAYGWVHNGEYKPSQIADFLILDVQLPRSLAYSYEKIVLNLD
YLAADYGERLEAHETAHAIRNTLRSQKIKTIMDNGLHQFLEDFVSRNNQL
SQQISEGYRFYA 
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